Study: Targeted drug combos block tumor cell growth

09/13/2007 | ScientificAmerican.com

A combination of targeted cancer drugs, also known as receptor tyrosine kinases, can outsmart tumor cells by preventing protein switches from inciting cell growth, U.S. researchers report. However, scientists said further studies are needed before the combination treatments can be recommended to cancer patients, given the drugs' possible toxicity risk and high cost.

View Full Article in:

ScientificAmerican.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Specialist RA AD Promo - 14000007LW
Abbott
Santa Ana, CA
Senior Regulatory Affairs Specialist Abbott Medical Devices (PDP Program) - 1400000AQG
Abbott
Santa Clara, CA
Director, Compliance & Ethics, US Operations
Bristol-Myers Squibb
Princeton, NJ
Manager, Educational Programs
The Food and Drug Law Institute
Washington, DC, DC
Global Medical Safety Director - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA